FAQs on the FDA Accelerated Approval of Zenbexus (Iberdomide) in Combination with Daratumumab and Dexamethasone for Relapsed/Refractory Multiple Myeloma
Frequently asked questions on the FDA-accelerated approval of Zenbexus (iberdomide), in combination with multiple myeloma indications.
Learn More
